SMAD2 and colorectal carcinoma: Figure 4D shows TG2 expression was increased by TGFβ1 treatment in RKO and SW480 cells with a corresponding increase in the phosphorylation of Smad2/3 shown in all CRC's which could be reduced by the neutralising TGFβ antibody.